---

Human Medicines Regulations 2012

Answer

Reforms to the Human Medicines Regulations 2012 are progressing under the Medicines and Medical Devices Act 2021. The Act supports the United Kingdom’s ambitions for the Life Sciences sector through regulations to increase innovation and support the development of new medical technologies. This includes placing the Early Access to Medicines Scheme on a statutory basis, supporting the continued safe deployment of COVID-19 and flu vaccines, and consulting on proposals for a new regulatory framework to enable innovative medicines to be manufactured and delivered at the point of care.

Through the Retained EU Law (Revocation and Reform) Bill, the Government is currently reviewing which retained European Union law should be repealed, reformed or preserved. The Government continues to work with a range of stakeholders to ensure that any such reforms maintain current standards in patient safety and public health. The Medicines and Healthcare products Regulatory Agency is participating in the review of all retained EU law within its responsibilities.

Secondary information

Type

Written question

Reference

104159

Session

2022-23

Subjects

EU law

Legislation

Retained EU Law (Revocation and Reform) Bill 2022-23

Human Medicines Regulations 2012

Link

View this Written question on www.parliament.uk